Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study

[1] Edwards IR(2000)Adverse drug reactions: definitions, diagnosis, and management Lancet 356 1255-1259

[2] Aronson JK(2002)Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern/St. Gallen, 1974–1993 Pharmacoepidemiol Drug Saf 11 159-163

[3] Hunziker T(2012)Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex Annu Rev Pharmacol Toxicol 52 401-431

[4] Bruppacher R(2014)Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls Curr Drug Metab 15 196-201

[5] Kuenzi UP(1995)The three-dimensional structure of peptide-MHC complexes Annu Rev Immunol 13 587-622

[6] Maibach R(2006)Pharmacological interaction of drugs with immune receptors: the p–i concept Allergol Int 55 17-25

[7] Braunschweig S(2015)The IPD and IMGT/HLA database: allele variant databases Nucleic Acids Res 43 D423-D431

[8] Halter F(2001)Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations Hum Immunol 62 1009-1030

[9] Bharadwaj M(2004)A marker for Stevens–Johnson syndrome Nature 428 6-7

[10] Illing P(2010)Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China Epilepsy Behav 19 405-408

[1] Edwards IR(2000)Adverse drug reactions: definitions, diagnosis, and management Lancet 356 1255-1259

[2] Aronson JK(2002)Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern/St. Gallen, 1974–1993 Pharmacoepidemiol Drug Saf 11 159-163

[3] Hunziker T(2012)Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex Annu Rev Pharmacol Toxicol 52 401-431

[4] Bruppacher R(2014)Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls Curr Drug Metab 15 196-201

[5] Kuenzi UP(1995)The three-dimensional structure of peptide-MHC complexes Annu Rev Immunol 13 587-622

[6] Maibach R(2006)Pharmacological interaction of drugs with immune receptors: the p–i concept Allergol Int 55 17-25

[7] Braunschweig S(2015)The IPD and IMGT/HLA database: allele variant databases Nucleic Acids Res 43 D423-D431

[8] Halter F(2001)Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations Hum Immunol 62 1009-1030

[9] Bharadwaj M(2004)A marker for Stevens–Johnson syndrome Nature 428 6-7

[10] Illing P(2010)Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China Epilepsy Behav 19 405-408